-
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre studyWallentin L, Lindhagen L, FRISC-II study group. -
National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI StudyZhang H, Jiang L, China PEACE Collaborative Group.
-
Managing Multivessel Coronary Artery Disease in Patients With ST-Elevation Myocardial Infarction: A Comprehensive ReviewPineda AM, Carvalho N, Gowani SA et al.
-
Wearable Cardioverter-Defibrillator after Myocardial InfarctionOlgin JE, Pletcher MJ, VEST Investigators et al.
-
Response by Kaier et al to Letter Regarding Article, “Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction”TE Kaier , R Twerenbold , C Puelacher et al.
-
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trialScholz KH, Maier SKG, Maier LS et al.
-
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus TicagrelorMotovska Z, Hlinomaz O, PRAGUE-18 Study Group et al.
-
Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarctionKaier TE, Twerenbold R, Marber M et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
